Abstract
INTRODUCTION
Cholestatic hepatitis, a liver disease that often results from chronic viral hepatitis, is mainly characterized by intrahepatic cholestasis, long durations of jaundice, poor appetite, skin itching, clay-colored stools, and increased levels of total bilirubin (TBil), direct bilirubin (DBil), total bile acid (TBA), and activities of alkaline phosphatase (ALP) and γ-glutamyl transferase (γ-GT). [1] [2] Cholestatic hepatitis can develop into fulminant hepatitis or cholestatic cirrhosis, which can increase patient mortality. Therefore, creating effective treatments for cholestatic hepatitis and slowing the progress of cirrhosis and its complications are problems that need to be solved. 3 Protecting the liver, promoting bile flow, relieving jaundice, and resisting viral infection are the treatment strategies used in clinical practice for cholestatic hepatitis. However, conventional Western Medicine is not very efficacious, and treatments are expensive. 4 For example, studies have shown that the first-line drug for cholestatic hepatitis, ursodeoxycholic acid, had no differences in the improvement of clinical symptoms, such as weakness and abdominal distention, compared to placebo. 5 Chronic viral cholestatic hepatitis, characterized under "jaundice" in Traditional Chinese Medicine (TCM), 6 is caused by damp-heat attack, which leads to toxic heat spreading throughout the body. The stagnation of toxic heat in the blood leads to blood heat stroke and blood stasis, resulting in a gradual exacerbation of jaundice. Therefore, the pathogenic basis for cholestatic hepatitis is stagnated blood and heat, and the therapeutic principle of activating blood, clearing heat, and removing toxins is used for treatment. [7] [8] [9] [10] [11] [12] [13] [14] Reports indicate that TCMs that protect the liver and relieve jaundice are effective in treating chronic cholestatic hepatitis, and herbs such as Chishao (Radix Paeoniae Rubra) are commonly used to clear heat, remove toxins, and cool blood. 15 He et al 16 used Chidantuihuang granules to treat acute and chronic viral cholestatic hepatitis with satisfactory curative effects. In this study, modified Chishaodanpi decoction (CSD-PD) was used to treat chronic viral cholestatic hepatitis compared with conventional therapy. The results could serve as a reference for the clinical treatment of chronic viral cholestatic hepatitis.
MATERIALS AND METHODS

Recruitment of participants
A total of 107 participants meeting the diagnostic criteria for viral hepatitis and cholestatic hepatitis. 17 Patients with alcohol-or drug-induced cholestatic hepatitis, and cholestatic hepatitis resulting from extrahepatic biliary obstruction, were excluded from this trial. The 107 patients (74 subjects with hepatitis B and 33 with hepatitis C) were randomly divided into a treatment group (54 cases) and a control group (53 cases). This study was approved by the ethics committee of the 150th Hospital of PLA. All patients signed an informed consent form.
Treatment
The patients in both groups were conventionally treated with potassium magnesium aspartate (30 mL), diammonium glycyrrhizinate (30 mL), glucurolactone (0.4 g), vitamin C (2.0 g), and lamivudine (100 mg, an antiviral drug), once a day. In addition, patients in the treatment group took modified CSDPD, 100 mL orally, twice a day in the morning and evening. The decoction consisted of Chishao (Radix Paeoniae Rubra) 60-120 g (over 180 g for severe cases), Yinchen 
Indexes of observation
Changes in jaundice, weaknesses, poor appetite, abdominal distention, skin itching, and adverse reactions were observed and recorded before and after treatment. The levels of TBil, DBil, TBA, and activities of ALP, ALT, AST, and -GT were determined before and after treatment.
Criteria for evaluating curative effect
A "significant effect" indicated relief of jaundice, weaknesses, poor appetite, abdominal distention, and skin itching, and normalization or more than 50% improvement in biochemical indexes of liver function. "Effective" indicated significant alleviation of jaundice, weaknesses, poor appetite, abdominal distention, and skin itching, and more than 25% and less than 50% improvement of biochemical indexes of liver function. "Ineffective" indicated no improvement, or exacerbation of symptoms. 18 The total effective rate was considered as all patients experiencing a significant effect and patients experiencing effective treatment divided by the total number of patients.
Statistical analysis
The statistical software SPSS 13.0 (Chicago, IL, USA) was used for analysis of experimental data. Analysis of variance and covariance was used to determine whether there were significant differences between the two groups. In descriptive analyses, continuous variables were expressed as mean±standard deviation (SD) or median (interquartile range), and categorical variables as absolute figures and percentages. Comparison of the measurement data was analyzed by t-test, and count data were analyzed by χ 2 test. P-values less than 0.05 were considered statistically significant.
RESULTS
Patient information
Among the 54 patients in the treatment group were 35 males and 19 females, aged 23-67 years, (49±10) years on average, with a disease duration of 7-24 months, (15 ± 6) months on average. Among the 53 patients in the control group were 32 males and 21 females, aged 24-69 years, (50±9) years on average, with a disease duration of 6-23 months, (15 ± 7) months on average. There were no significant differences in gender, age, disease duration, symptoms, signs, or laboratory findings between the two groups (P>0.05, Tables 1-3) .
Improvements in main symptoms and signs
After treatment, improvements in jaundice, weakness, poor appetite, abdominal distention, and skin itching were significantly better in the treatment group than those in the control group (P<0.05, Table 4 ).
Comparison of clinical effects
In the treatment group, there was a significant effect in 43 patients, effective treatment in seven patients, and ineffective treatment in four patients. In the control group, there was a significant effect in 21 patients, effective treatment in 12 patients, and ineffective treatment in 20 patients. The total effective rate was 92.6% in the treatment group and 62.3% in the control group, which is significantly different (P<0.05) ( Table 5) .
Changes in laboratory findings of liver function before and after treatment After treatment, the liver function of both groups improved significantly (P<0.05). The liver function improvement was significantly greater in the treatment group than in the control group (P<0.05) ( Table 6 ).
Adverse reactions
Patients in the control group had no obvious adverse reactions. Three patients in the treatment group had mild adverse reactions such as increased bowel movement frequency and mild stomachache in the first week of treatment. However, the patients could tolerate the adverse reaction. The mild adverse reactions gradually disappeared as treatment continued. All patients finished the treatment. Average disease duration (month) 15±7 15±6 Notes: control group was treated with conventional Western Medicine. Treatment group was treated with modified CSDPD in addition to conventional Western Medicine. CSDPD: Chishaodanpi decoction. There were no significant differences in gender, age, or average disease duration between the two groups before treatment (P>0.05). Table 1 Comparison of general data between the two groups before treatment Notes: control group was treated with conventional Western Medicine. Treatment group was treated with modified CSDPD in addition to conventional Western Medicine. CSDPD: Chishaodanpi decoction. There were no significant differences in the symptoms and signs between the two groups before treatment (all P>0.05). Table 2 Comparison of symptoms and signs between the two groups before treatment [(n) %] Table 3 Comparison of laboratory findings in liver function between the two groups before treatment ( x ±s) Notes: control group was treated with conventional Western Medicine. Treatment group was treated with modified CSDPD in addition to conventional Western Medicine. TBil: total bilirubin; DBil: direct bilirubin; TBA: total bile acid; ALP: activities of alkaline phosphatase; γ-GT: γ-glutamyl transferase; ALT: alanine aminotransferase; AST: aspartate aminotransferase; CSDPD: Chishaodanpi decoction. There were no significant differences in the levels of TBil, DBil, TBA, ALP, ALT, AST, and γ-GT between the two groups before treatment (all P>0.05).
characterized by intrahepatic cholestasis, results from necrosis of hepatic cells, blockage of bile, and eventual obstruction of bile capillaries in the portal area. 19 In patients with chronic viral cholestatic hepatitis, there are significant increases in serum bilirubin (mainly DBil) and activities of ALP and γ-GT. During cholestasis, it is difficult to treat jaundice with the usual treatments such as protecting the liver, promoting bile flow, and improving liver enzyme levels, and there is no specific treatment for the disease. Prolonged cholestasis can lead to cirrhosis and eventually liver and kidney failure. 20 Chronic viral cholestatic hepatitis, which is characterized as "jaundice" in TCM, 6 is caused by excessive damp-heat, which leads to toxic heat spreading throughout the body. The stagnation of toxic heat in the blood forms blood stasis, which causes a gradual exacerbation of jaundice. Therefore, the pathogenic basis for the disease is stagnated blood and heat. The therapeutic principle of activating blood, clearing heat, removing toxins, and inducing purgation should be used to treat chronic viral cholestatic hepatitis. [7] [8] [9] [10] [11] [12] [13] [14] In the CSDPD prescription, Chishao (Radix Paeoniae Rubra), Mudanpi (Cortex Moutan Radicis), Danshen (Radix Salviae Miltiorrhizae), and Dihuang (Radix Rehmanniae) can cool and activate the blood. Dangshen (Radix Codonopsis), Banxia (Rhizoma Pinelliae), and Baizhu (Rhizoma Atractylodis Macrocephalae) can invigorate the spleen and harmonize the stomach. Yinchen (Herba Artemisia Capillaris), Zhizi (Fructus Gardeniae), Fuling (Poria), Zexie (Rhizoma Alismatis), Cheqianzi (Semen Plantaginis), and Dahuang (Radix Et Rhizoma Rhei Palmati) can clear heat and drain dampness to promote the elimination of damp-heat from the excrement and urine. Prepared Gancao (Radix Glycyrrhizae) can harmonize the other drugs in the prescription. Chishao (Radix Paeoniae Rubra), a blood-activating and stasis-resolving herb, acts on the liver meridian to enter the blood, remove heat, eliminate stasis, and purge liver-fire. Clinical practice shows that Chishao (Radix Pae- Table 6 Comparison of liver function before and after treatment in the same group and after treatment between the two groups ( x ±s)
oniae Rubra) and Mudanpi (Cortex Moutan Radicis) at large dosages can significantly improve jaundice. Modern pharmacological studies indicate that total Paeonia glycosides, a main component of Chishao (Radix Paeoniae Rubra), can cool and activate blood, resolve stasis, lower blood viscosity, relieve endotoxemia, remove jaundice, inhibit the production of plasma thromboxane, improve liver microcirculation, prevent liver fibrosis, and promote the repair and regeneration of injured liver cells. Therefore, Paeonia glycosides have an excellent therapeutic effect on cholestatic hepatitis. [21] [22] [23] Mudanpi (Cortex Moutan Radicis) is a bitter and pungent herb that is slightly cold in nature, and is mainly used to treat pathogenic heat attacking the blood, and blood stasis. The therapeutic action of Mudanpi (Cortex Moutan Radicis) is related to the heart, liver, and kidney meridians and it can clear heat from the blood, promote blood circulation, and remove blood stasis. Coumarin, an active ingredient of Yinchen (Herba Artemisia Capillaris), can protect hepatic cell membranes, prevent hepatic necrosis, promote liver cell regeneration, improve liver microcirculation, inhibit glucuronidase activity, strengthen liver detoxifying activity, and dilate the bile duct. 24, 25 6,7-Dimethylesculetin, another active ingredient of Yinchen (Herba Artemisia Capillaris) can normalize gallbladder function, resist lipid peroxidation, and prevent liver cell necrosis and hepatic steatosis, which promotes liver cell regeneration and protects the integrity of liver cell membranes. 26, 27 Danshen (Radix Salviae Miltiorrhizae) can remove stasis and activate blood. The combination of Danshen (Radix Salviae Miltiorrhizae) and other herbs for cooling and activating blood has an excellent therapeutic effect on jaundice. Dahuang (Radix Et Rhizoma Rhei Palmati), which is bitter in taste and cool in nature, can remove blood stasis, and is considered to be the main herb for cooling blood and treating jaundice. The combined use of Dahuang (Radix Et Rhizoma Rhei Palmati) and other herbs for cooling blood is also an effective therapy for jaundice. 28 Smooth defecation can block or reduce the enterohepatic circulation of bilirubin and accelerate the excretion of bilirubin. The combination of the herbs in CSDPD can eliminate damp-heat and resolve blood stasis to cure jaundice, and can complement effective Western drugs. The results from this trial indicate that the therapeutic effect of CSDPD combined with conventional Western Medicine on chronic viral cholestatic hepatitis is superior to that of conventional Western Medicine alone. The total effective rate of CSDPD combined with conventional Western Medicine is much higher than that of conventional Western Medicine. This therapy is safe and effective on chronic viral cholestatic hepatitis. However, there are also limitations to our study. Because of small samples and short observational time, studies with large samples and longer durations should be conducted. Moreover, a detailed study on the mechanism of CSDPD should be performed.
